Literature DB >> 12370338

Cutting edge: a natural P451L mutation in the cytoplasmic domain impairs the function of the mouse P2X7 receptor.

Sahil Adriouch1, Claudia Dox, Vivienne Welge, Michel Seman, Friedrich Koch-Nolte, Friedrich Haag.   

Abstract

The P2X7 receptor (P2X(7)R) is an ATP-gated channel that mediates apoptosis of cells of the immune system. The capacity of P2X(7)R to form large pores depends on its large cytoplasmic tail, which harbors a putative TNFR-related death domain. Previous transfection studies indicated that mouse P2X(7)R forms pores much less efficiently than its counterparts from humans and rats. In this study, we demonstrate that an allelic mutation (P451L) in the predicted death domain of P2X(7)R confers a drastically reduced sensitivity to ATP-induced pore formation in cells from some commonly used strains of mice, i.e., C57BL/6 and DBA/2. In contrast, most other strains of mice, including strains derived from wild mice, carry P451 at this position as do rats and humans. The effects of the P451L mutation resemble those of the E496A mutation in human P2X(7)R. These P2X(7)R mutants may provide useful tools to decipher the molecular mechanisms leading to pore formation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12370338     DOI: 10.4049/jimmunol.169.8.4108

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  82 in total

1.  A truncated P2X7 receptor variant (P2X7-j) endogenously expressed in cervical cancer cells antagonizes the full-length P2X7 receptor through hetero-oligomerization.

Authors:  Ying-Hong Feng; Xin Li; Liqin Wang; Lingying Zhou; George I Gorodeski
Journal:  J Biol Chem       Date:  2006-04-18       Impact factor: 5.157

Review 2.  Molecular and functional properties of P2X receptors--recent progress and persisting challenges.

Authors:  Karina Kaczmarek-Hájek; Eva Lörinczi; Ralf Hausmann; Annette Nicke
Journal:  Purinergic Signal       Date:  2012-05-01       Impact factor: 3.765

3.  Identification of Thr283 as a key determinant of P2X7 receptor function.

Authors:  M T Young; P Pelegrin; A Surprenant
Journal:  Br J Pharmacol       Date:  2006-08-29       Impact factor: 8.739

4.  Cloning and pharmacological characterization of the guinea pig P2X7 receptor orthologue.

Authors:  E Fonfria; W C Clay; D S Levy; J A Goodwin; S Roman; G D Smith; J P Condreay; A D Michel
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

5.  Invited Lectures : Overviews Purinergic signalling: past, present and future.

Authors: 
Journal:  Purinergic Signal       Date:  2006-05-15       Impact factor: 3.765

6.  Quantifying Ca2+ current and permeability in ATP-gated P2X7 receptors.

Authors:  Xin Liang; Damien S K Samways; Kyle Wolf; Elizabeth A Bowles; Jennifer P Richards; Jonathan Bruno; Sébastien Dutertre; Richard J DiPaolo; Terrance M Egan
Journal:  J Biol Chem       Date:  2015-02-02       Impact factor: 5.157

7.  P2X7 receptor-Pannexin1 complex: pharmacology and signaling.

Authors:  R Iglesias; S Locovei; A Roque; A P Alberto; G Dahl; D C Spray; E Scemes
Journal:  Am J Physiol Cell Physiol       Date:  2008-07-02       Impact factor: 4.249

8.  BALB/c and C57BL6 mouse strains vary in their ability to heal corneal epithelial debridement wounds.

Authors:  Sonali Pal-Ghosh; Gauri Tadvalkar; Rosalyn A Jurjus; James D Zieske; Mary Ann Stepp
Journal:  Exp Eye Res       Date:  2008-09-06       Impact factor: 3.467

Review 9.  P2X receptor channels in chronic pain pathways.

Authors:  Louis-Philippe Bernier; Ariel R Ase; Philippe Séguéla
Journal:  Br J Pharmacol       Date:  2017-08-17       Impact factor: 8.739

10.  Characterisation of the R276A gain-of-function mutation in the ectodomain of murine P2X7.

Authors:  Sahil Adriouch; Felix Scheuplein; Robert Bähring; Michel Seman; Olivier Boyer; Friedrich Koch-Nolte; Friedrich Haag
Journal:  Purinergic Signal       Date:  2009-02-21       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.